License was Viridian Therapeutics, Inc.\DE’s largest product and service line in fiscal 2025, bringing in $70.00M of $70.85M (99%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| License | — | — | — | $70.00M | |||||
| Reimbursement Revenue | — | — | — | — | |||||
| Research & Development Reimbursable Costs | — | — | — | — | |||||
| Milestone Payments | — | — | — | — | |||||
| Collaboration Revenue | $1.80M | — | — | — | |||||
| Grant Revenue | — | — | — | — | |||||
| Collaboration | — | $314.00K | $302.00K | $849.00K | |||||
| Total | $1.80M | $314.00K | $302.00K | $70.85M |
Viridian Therapeutics, Inc.\DE brought in $70.85M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Viridian Therapeutics, Inc.\DE regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $302.00K. License was the largest at $70.00M (98.8%), ahead of Collaboration at $849.00K (1.2%).
Viridian Therapeutics, Inc.\DE began breaking out License in fiscal 2025 and Collaboration in fiscal 2023. Viridian Therapeutics, Inc.\DE stopped reporting Collaboration Revenue as a separate line after fiscal 2022, when it brought in $1.80M.
Viridian Therapeutics, Inc.\DE (VRDN) reports its revenue by product and service. In fiscal 2025, License was its largest product and service line, bringing in $70.00M (98.8% of the total), followed by Collaboration at $849.00K (1.2%).
License was Viridian Therapeutics, Inc.\DE's largest product and service line in fiscal 2025, bringing in $70.00M, or 98.8% of the $70.85M total across its two product and service lines.
Every figure comes from Viridian Therapeutics, Inc.\DE's annual financial filings, as reported. Each line keeps the name Viridian Therapeutics, Inc.\DE gives it, and years follow its fiscal calendar.
Viridian Therapeutics, Inc.\DE's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.